Multiple Sclerosis Disease Activity and Disability Following Discontinuation of Natalizumab for Pregnancy
Multiple Sclerosis Disease Activity and Disability Following Discontinuation of Natalizumab for Pregnancy is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Multiple Sclerosis Disease Activity and Disability Following Discontinuation of Natalizumab for Pregnancy have?
Multiple Sclerosis Disease Activity and Disability Following Discontinuation of Natalizumab for Pregnancy has 72 citations in the OpenAlex counts ScholarIQ stores.
When was Multiple Sclerosis Disease Activity and Disability Following Discontinuation of Natalizumab for Pregnancy published?
Multiple Sclerosis Disease Activity and Disability Following Discontinuation of Natalizumab for Pregnancy has 2022 year in the ScholarIQ index.
What is the open-access status of Multiple Sclerosis Disease Activity and Disability Following Discontinuation of Natalizumab for Pregnancy?
Multiple Sclerosis Disease Activity and Disability Following Discontinuation of Natalizumab for Pregnancy has gold oa status in the ScholarIQ index.
What is the DOI of Multiple Sclerosis Disease Activity and Disability Following Discontinuation of Natalizumab for Pregnancy?
The DOI for Multiple Sclerosis Disease Activity and Disability Following Discontinuation of Natalizumab for Pregnancy is on the source record.
What is the PMID of Multiple Sclerosis Disease Activity and Disability Following Discontinuation of Natalizumab for Pregnancy?
The PMID for Multiple Sclerosis Disease Activity and Disability Following Discontinuation of Natalizumab for Pregnancy is on the source record.
What is the OpenAlex record for Multiple Sclerosis Disease Activity and Disability Following Discontinuation of Natalizumab for Pregnancy?
The OpenAlex for Multiple Sclerosis Disease Activity and Disability Following Discontinuation of Natalizumab for Pregnancy is on the source record.